Cite
HARVARD Citation
Nakayama, S. et al. (2018). Nonsmall Cell Lung Carcinoma with Giant Cell Features Expressing Programmed Death-Ligand 1: A Report of a Patient Successfully Treated with Pembrolizumab. Case reports in oncological medicine. p. . [Online].